Rehab From Drug – Drug Rehab Centers – Rehab Treatment For Drug Addiction – Drug Rehab

October 14, 2009
by admin
0 comments

ATL1103 drug that targets the growth hormone receptor moves into clinical development

Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species — mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, … Continue reading